Literature DB >> 24238520

Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration in intrapulmonary lesions.

Hui Zhao1, Zhen Xie, Zu-Li Zhou, Xi-Zhao Sui, Jun Wang.   

Abstract

BACKGROUND: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is considered to have high value in the staging of mediastinal lymph nodes in lung cancer. The current study was conducted to investigate the diagnostic value of EBUS-TBNA in intrapulmonary lesions located near the central airway.
METHODS: From September 2009 to March 2013, 66 patients with pulmonary masses located close to the central airways suspected to be lung cancer were accessed by EBUS-TBNA. Conventional bronchoscopic biopsy before EBUS-TBNA was nondiagnostic in all cases. If EBUS-TBNA did not result in a formal pathological diagnosis of malignancy, patients were subsequently referred for a surgical procedure.
RESULTS: Among the 66 cases, 59 were confirmed as pulmonary malignancies by EBUS-TBNA, of which 48 cases were non-small cell lung cancer, nine were small cell lung cancer, and two were metastatic lung tumors. No evidence of malignancy was found by biopsy and histopathological examination in the other seven cases. Thoracoscopy or thoracotomy was subsequently undergone for them. Postoperative pathological examinations confirmed three cases of squamous cell carcinoma of the lung, one case of lymphoma, two cases of sclerosing hemangioma, and one case of pulmonary tuberculoma. The definitive diagnosis rate of EBUS-TBNA for intrapulmonary lesions near the central airway was 89.4%. The sensitivity, specificity, and accuracy of EBUS-TBNA in distinguishing benign from malignant intrapulmonary lesions were 93.7%, 100.0%, and 93.9%, respectively. The positive and negative predictive values were 100.0% and 42.9%, respectively. The EBUS-TBNA procedures were well-tolerated by all patients. No associated complications were observed.
CONCLUSIONS: For intrapulmonary lesions near the central airway highly suspected of cancer, EBUS-TBNA has satisfactory diagnostic value. However, the negative predictive value of this technique is low, so negative results obtained by EBUS-TBNA should be confirmed by other methods.

Entities:  

Mesh:

Year:  2013        PMID: 24238520

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

1.  Endobronchial ultrasound-guided transbronchial needle aspiration: unraveling myths of mass in the chest.

Authors:  Rui Wang; Guangqiao Zeng
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

2.  Percutaneous CT-guided needle biopsies of musculoskeletal tumors: a 5-year analysis of non-diagnostic biopsies.

Authors:  Connie Y Chang; Ambrose J Huang; Miriam A Bredella; Martin Torriani; Elkan F Halpern; Daniel I Rosenthal; Dempsey S Springfield
Journal:  Skeletal Radiol       Date:  2015-09-04       Impact factor: 2.199

Review 3.  Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in solitary mediastinal, hilar lymphadenectasis, or peribronchial lesions: Six cases reports and review of literature.

Authors:  Yan-Bin Chen; Jun-Hong Jiang; Jing-Yu Mao; Jian-An Huang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 4.  A quarter century of EUS-FNA: Progress, milestones, and future directions.

Authors:  Irina Mihaela Cazacu; Adriana Alexandra Luzuriaga Chavez; Adrian Saftoiu; Peter Vilmann; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

Review 5.  Present status and perspectives of endosonography 2017 in gastroenterology.

Authors:  Michael Hocke; Barbara Braden; Christian Jenssen; Christoph F Dietrich
Journal:  Korean J Intern Med       Date:  2017-11-23       Impact factor: 2.884

6.  Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer.

Authors:  Justyna Błach; Małgorzata Frąk; Pawel Krawczyk; Juliusz Pankowski; Adam Pankowski; Jarosław Buczkowski; Artur Szlubowski; Jan Siwiec; Piotr Krudyś; Marek Michnar; Robert Kieszko; Janusz Milanowski
Journal:  BMJ Open       Date:  2021-08-09       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.